Kenvue Inc. Common Stock vs Onto Innovation — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Onto Innovation trades at $294.2 (market cap $14.36B). The key difference: Kenvue Inc. Common Stock is far larger — about 2.4× Onto Innovation's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Onto Innovation pays none. Which is the better fit depends on your goals.
| KVUE | ONTO | |
|---|---|---|
Market Cap | $34.06B | $14.36B |
Volume | 23,267,228 | 761,617 |
Sector | Consumer Staples | Technology |
52-Week High | $19.83 | $378.45 |
52-Week Low | $14.11 | $121.34 |
Enterprise Value | $41.56B | $13.95B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 6 Days |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →